ASNRT — Arab Society of Nephrology and Renal Transplantation

Adding Finerenone to SGLT2 Inhibitors and Long-Term Kidney Outcomes in Diabetic Kidney Disease

Among patients with DKD receiving RASi and SGLT2i therapy, the addition of finerenone was associated with greater proteinuria reduction and a significant improvement in the post-initial dip eGFR slope, suggesting that TCT may offer an additional renoprotective strategy in DKD.

Category

Research

Source

Diabetes, Obesity & Metabolism

Read the full abstract on PubMed

More from ASNRT News

Browse the latest news, society announcements, KDIGO guideline updates, and AJNT issue releases on the ASNRT newsroom.

All news · ASNRT home